Senior insider sale
Chief Financial Officer at CRISPR THERAPEUTICS AG — senior position signals high conviction
$4.45M
74.67K shares
What this filing means
PRASAD RAJU plans to sell 74.67K shares of CRISPR THERAPEUTICS AG valued at approximately $4.45M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/22/2026ACC: 0001950047-26-000625
Officer· Chief Financial Officer
Since Mar 2023
74.67K
Shares to sell
$4.45M
Approx. market value
34.97K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
1/22/2026
34.97KTotal acquired34.97K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/22/2026 | Stock Option Exercise Cash | 34.97K | — |
| Total | 34.97K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
29.70K
Market value
$1.79M
1/6/2026
—Completed
Units to sell
10K
Market value
$559.5K
12/22/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
34.97K
Market value
$2.11M
1/22/2026
Total
Units
74.67K
Value
$4.45M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/6/2026 | 29.70K | $1.79M | — | Completed |
12/22/2025 | 10K | $559.5K | — | Completed |
| Planned — Approximate Date | ||||
1/22/2026 | 34.97K | $2.11M | NASDAQ | Planned |
| Total | 74.67K | $4.45M | ||